Accufast Bio Indicators

The University of Nebraska Medical Center, a state agency in Nebraska, awarded a purchase order (PO #4800184412) to Healthmark Industries Co Inc on March 5, 2026, for the delivery of Accufast Bio Indicators to the Buffett Cancer Center in Omaha, Nebraska. The contract encompasses two boxes of Accufast Bio Indicators (material number 61301606637) at a unit price of $197.25 per box, for a total contract value of $394.50. The performance period spans from the award date of March 5, 2026, through the completion date of March 12, 2026.

The purchase order is governed by the Standard Terms of Purchase established by the University of Nebraska Board of Regents and specifies payment terms of Net 30 with Free on Board Destination freight prepaid. Delivery will occur at the Buffett Cancer Center Dock-Comparative Medi facility, with unloading to be performed by the receiving entity. The vendor is required to acknowledge acceptance of the order within ten days and must ensure that the purchase order number appears on all packages, invoices, and related documentation, with packing slips accompanying all shipments. Payment will be processed through Nebraska State Treasury warrants to the University of Nebraska Medical Center's Accounts Payable office.